Molecular mechanisms of autoreactive B cell activation
Molecular mechanisms of autoreactive B cell activation
批准号:
7346917
负责人:
Joseph Dal Porto
金额:
$23.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2008-12-31
关键词:
AddressAffinityAttentionAutoantibodiesAutoimmune DiseasesAutoimmune ProcessAutoimmunityB Cell ProliferationB-Cell ActivationB-LymphocytesBoxingCD4 Positive T LymphocytesCell Culture SystemCell ProliferationCellsComplementConditionCytotoxic T-LymphocytesDendritic CellsGenerationsHelper-Inducer T-LymphocyteIgEImmuneImmunoglobulin Class SwitchingImmunoglobulin Switch RecombinationIn VitroInterferon Type IILupusMediatingModelingMolecularMusMutant Strains MicePathogenesisPathway interactionsPlayProductionRegulationRoleS cerevisiae SWI3 proteinSTAT1 geneSpecific qualifier valueT-LymphocyteT-bet proteinUniversitiesWashingtonWorkautoreactive B cellbasecytokineds-DNAmacrophagemedical schoolsnovelresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our recent studies have indicated a critical role for the T-box transcription factor T-bet in the regulation of class switching in B cells as well as in autoantibody production in systemic autoimmune disease: T-bet deficiency dramatically impairs IFN-gamma-mediated class switching to IgG2a as well as the generation of autoantibodies in the MRL/Ipr murine model of lupus, and conversely enhances IL-4-related responses, such as IgE production. Using genetically mutant mice and in vitro cell culture systems, we propose here to further delineate the role of T-bet in both conventional and autoimmune B cell responses by defining and characterizing the molecular pathways in which this novel pathogenic and therapeutic target regulates isotype switching, cellular proliferation, and the activation of mature, autoreactive B lymphocytes.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金